THE IMPACT OF COVID-19 PANDEMIC ON TYPE 1 DIABETES MELLITUS INCIDENCE AND ITS CLINICAL PRESENTATION IN CHILDREN AND ADOLESCENTS: ONE CENTER'S EXPERIENCE

  • Sandra Stankovic Paediatric Clinic Nis
  • Zlatibor Gocic Paediatric Clinic Nis
  • Milan Golubovic Paediatric Clinic Nis
  • Milica Stojkovic Paediatric Clinic Nis
  • Dusan Miljkovic University Clinical Center Nis
  • Suzana Stajic Paediatric Clinic Nis
  • Andjela Ognjanovic Paediatric Clinic Nis
  • Marija Topalovic Clinic for pulmonary diseases Nis
  • Vesna Cvetkovic Paediatric Clinic Nis
  • Ljiljana Saranac Paediatric Clinic Nis
  • Milena Manojlovic Paediatric Clinic Nis
  • Sasa Zivic
  • Jelena Vucic Paediatric Clinic Nis
Keywords: COVID 19, child, DKA

Abstract


The outbreak of the COVID-19 pandemic has a drastic impact on health systems. The aim of this research is to present the incidence and clinical picture of newly diagnosed diabetes in children in our institution during the first year COVID-19 pandemic and to compare data with previous years. A total of 41 children were newly diagnosed with T1DM1. There were two non-significant join point periods with an annual percentage increase (2007-2012: APC 8,94%), followed by a decrease (2012-2015: APC -6,88%) and a statistically significant increase (2015-2020: APC 14,20%). During COVID year there were larger number of newly diagnosed children, but without statistical significance. The percentage  of children presenting with DKA in the time of T1DM diagnosis was significantly higher compared to pre COVID-19 period (84.8% vs 34.6%; p < 0.001). Our results suggest a potential diabetogenic effect of the COVID 19 infection. Larger trials with long term follow ups are needed. Drastic increase of DKA on T1DM onset during COVID year urge need for better prevention measures.

References

DiMeglio LA, Albanese-O’Neill A, Munoz CE, Maahs DM. COVID-19 and Children With Diabetes-Updates, Unknowns, and Next Steps: First, Do No Extrapola-tion. Diabetes Care 2020;43:2631-4. [CrossRef] [PubMed]

Duca LM, Wang B, Rewers M, Rewers A. Diabetic ketoacidosis at diagnosis of type 1 diabetes predicts poor long-term glycemic control. Diabetes Care 2017; 40(9):1249-55. [CrossRef] [PubMed]

EURODIAB Substudy 2 Study Group. Rapid early growth is associated with increased risk of childhood type 1 diabetes in various European populations. Diabetes Care 2002;25:1755-60. [CrossRef] [PubMed]

European Centre for Disease Prevention and Control. Data on 14-day notification rate of new COVID-19 cases and deaths [dataset]. 2021 april 22nd "cited 2021 april 22nd". Available from: URL: https://www.ecdc.europa.eu/en/publications-data/data-national-14-day-notification-rate-covid-19 .

Fu J, Zhou B, Zhang L, Balaji KS, Wei C, Liu X, et al. Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19. Mol Biol Rep 2020;14:1–10. [CrossRef] [PubMed]

Ho J, Rosolowsky E, Pacaud D, Huang C, Lemay JA, Brockman N, et al. Diabetic ketoacidosis at type 1 diabetes diagnosis in children during the COVID-19 pandemic. Pediatr Diabetes 2021;1-6. [CrossRef] [PubMed]

International Diabetes Federation (Belgium). IDF Dia-betes Atlas. 8th edition. Brussels: International Diabe-tes Federation; 2017.

Jesic MD, Jesic MM, Stanisavljevic D, Zdravkovic V, Bojic V, Vranjes M et al. Ketoacidosis at presentation of type 1 diabetes mellitus in children: a retrospective 20-year experience from a tertiary care hospital in Serbia. Eur J Pediatr 2013;172:1581-5. [CrossRef] [PubMed]

Joinpoint Regression Program (computer program). Version 4.8.0.1. Statistical methodology and applica-tions branch, Surveillance Research Program, National Cancer Institute; 2020.

Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty 2020;9(1):45. [CrossRef] [PubMed]

Sipetic S, Maksimovic J, Vlajinac H, Ratkov I, Sajic S, Zdravkovic D et al. Rising incidence of type 1 diabetes in Belgrade children aged 0-14 years in the period from 1982 to 2005. J Endocrinol Investig 2013; 36:307-12. [PubMed]

Stankovic S, Vukovic R, Vorgucin I, Zdravkovic V,  Folic N, Zivic S et al. First report on nationwide prevalence of paediatric type 1 diabetes in Serbia and temporal trends of diabetes ketoacidosis at diagnosis-a multicentre study. J Pediatr Endocrinol Metab 2020; 34(2):225-9. [CrossRef] [PubMed]

The DIAMOND Project Group. Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med 2006;23:857-66. [CrossRef] [PubMed]

Tittel SR, Rosenbauer J, Kamrath C, Ziegler J, Reschke F, Hammersen J, et al. Did the COVID-19 lockdown affect the incidence of pediatric type 1 diabetes in Germany? Diabetes Care 2020;43(11):e172-e173. [CrossRef] [PubMed]

Unsworth R, Wallace S, Oliver NS, Yeung S, Kshirsagar A, Naidu H, et al. New-onset type 1 diabetes in children during COVID-19: multicenter regional findings in the U.K. Diabetes Care 2020; 43(11):e170-e171. [CrossRef] [PubMed]

Vukovic R, Jesic MD, Vorgucin I, Stankovic S, Folic N, Milenkovic T et al. 2018; First report on the nation-wide incidence of type 1 diabetes and ketoacidosis at onset in children in Serbia: a multicenter study. Eur Jour Pediatr 2013;177:1155-62. [CrossRef] [PubMed]

Wolfsdorf JI, Glaser N, Agus M, Fritch M, Hanas R, Rewers A, et al. ISPAD Clinical Practice Consensus Guidelines 2018: Diabetic ketoacidosis and hypergly-caemic hyperosmolar state. Pediatr Diabetes 2018; 19:155-77. [CrossRef] [PubMed]

Yang L, Han Y, Nilsson-Payant BE, Gupta V, Wang P, Duan X, et al. A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and  organoids. Cell StemCell 2020;27:125-36.e7. [CrossRef] [PubMed]

You WP, Henneberg M. Type 1 diabetes prevalence increasing globally and regionally: the role of natural selection and life expectancy at birth. BMJ Open Diabetes Res Care 2016;4:e000161. [CrossRef] [PubMed]

Published
2022/04/12
Section
Original article